⌘K
Loading ticker…
Corbus Pharmaceuticals Holdings, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.1%, relative volume 5.08×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
31 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CRBP is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $5M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRBP Jan avg: 90.88% median: 20.98% win: 75% σ: 166.86% n: 4 2022-04-12 → 2026-05-29 | CRBP Feb avg: -9.59% median: -9.63% win: 50% σ: 23.97% n: 4 2022-04-12 → 2026-05-29 | CRBP Mar avg: 37.51% median: 18.28% win: 75% σ: 74.30% n: 4 2022-04-12 → 2026-05-29 | CRBP Apr avg: 8.91% median: 5.22% win: 60% σ: 22.48% n: 5 2022-04-12 → 2026-05-29 | CRBP May avg: -1.52% median: -0.67% win: 40% σ: 14.13% n: 5 2022-04-12 → 2026-05-29 | CRBP Jun avg: -8.84% median: -11.94% win: 25% σ: 10.80% n: 4 2022-04-12 → 2026-05-29 (current) | CRBP Jul avg: 14.50% median: 15.91% win: 75% σ: 21.55% n: 4 2022-04-12 → 2026-05-29 | CRBP Aug avg: -3.76% median: 1.23% win: 75% σ: 11.11% n: 4 2022-04-12 → 2026-05-29 | CRBP Sep avg: -14.27% median: -12.91% win: 25% σ: 41.60% n: 4 2022-04-12 → 2026-05-29 | CRBP Oct avg: -16.73% median: -20.18% win: 0% σ: 8.64% n: 4 2022-04-12 → 2026-05-29 | CRBP Nov avg: 19.75% median: 17.20% win: 75% σ: 22.95% n: 4 2022-04-12 → 2026-05-29 | CRBP Dec avg: -29.04% median: -31.62% win: 0% σ: 14.10% n: 4 2022-04-12 → 2026-05-29 |